These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2164372)

  • 1. The importance of DNA flow cytometry in node-negative breast cancer.
    Winchester DJ; Duda RB; August CZ; Goldschmidt RA; Wruck DM; Rademaker AW; Winchester DP; Merkel DE
    Arch Surg; 1990 Jul; 125(7):886-9. PubMed ID: 2164372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry.
    Clark GM; Dressler LG; Owens MA; Pounds G; Oldaker T; McGuire WL
    N Engl J Med; 1989 Mar; 320(10):627-33. PubMed ID: 2918874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
    Haffty BG; Toth M; Flynn S; Fischer D; Carter D
    J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
    Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
    Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting.
    Wong SW; Rangan AM; Bilous AM; Boyages J; Gebski V; Benson EM
    Pathology; 1999 May; 31(2):90-4. PubMed ID: 10399161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
    Pinto AE; André S; Soares J
    J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients.
    Lewis WE
    Cancer; 1990 May; 65(10):2315-20. PubMed ID: 2346915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA index, S-phase fraction, histological grade and prognosis in breast cancer.
    O'Reilly SM; Camplejohn RS; Barnes DM; Millis RR; Allen D; Rubens RD; Richards MA
    Br J Cancer; 1990 May; 61(5):671-4. PubMed ID: 2159768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
    Dressler LG; Seamer LC; Owens MA; Clark GM; McGuire WL
    Cancer; 1988 Feb; 61(3):420-7. PubMed ID: 3338012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
    Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
    Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.
    Fisher B; Gunduz N; Costantino J; Fisher ER; Redmond C; Mamounas EP; Siderits R
    Cancer; 1991 Oct; 68(7):1465-75. PubMed ID: 1893345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Flow cytometry detected S-phase fraction and ploidy as prognostic parameters in primary, node-negative breast cancer].
    Winter K; Eidtmann H; Jonat W
    Geburtshilfe Frauenheilkd; 1994 May; 54(5):291-4. PubMed ID: 8050690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast.
    Noguchi M; Taniya T; Ohta N; Koyasaki N; Miyazaki I; Mizukami Y
    Breast Cancer Res Treat; 1991 Sep; 19(1):23-31. PubMed ID: 1661623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study.
    Ewers SB; Attewell R; Baldetorp B; Borg A; Fernö M; Långström E; Killander D
    Breast Cancer Res Treat; 1992; 24(2):115-26. PubMed ID: 8443399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?
    Keyhani-Rofagha S; O'Toole RV; Farrar WB; Sickle-Santanello B; DeCenzo J; Young D
    Cancer; 1990 Apr; 65(7):1577-82. PubMed ID: 2311069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients.
    Clark GM; Mathieu MC; Owens MA; Dressler LG; Eudey L; Tormey DC; Osborne CK; Gilchrist KW; Mansour EG; Abeloff MD
    J Clin Oncol; 1992 Mar; 10(3):428-32. PubMed ID: 1740681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epithelial growth factor receptors (EGF-R) and DNA flow cytometry in addition to lymph node and hormone receptor status as prognostic factors in primary breast cancer].
    Costa SD; Kaufmann M; Fabbro D; Tokus M; Feichter G; Klinga K; Bastert G
    Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):375-8. PubMed ID: 2544476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials.
    Witzig TE; Ingle JN; Schaid DJ; Wold LE; Barlow JF; Gonchoroff NJ; Gerstner JB; Krook JE; Grant CS; Katzmann JA
    J Clin Oncol; 1993 Feb; 11(2):351-9. PubMed ID: 8426213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DNA ploidy is an independent prognostic biomarker in breast invasive ductal carcinoma].
    Pinto AE; Pereira T; Silva GL; Ferreira MC; André S
    Acta Med Port; 2012; 25(6):399-407. PubMed ID: 23534591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.